Latest KFF Health News Content

Latest KFF Health News Stories

Banner Health To Pay $18 Million To Settle Whistleblower Case Involving False Medicare Claims

Morning Briefing

Former employee Cecilia Guardiola said she discovered that Banner hospitals billed an “inordinate and improper number of short-stay claims, particularly those for expensive cardiac procedures,” according to the Justice Department statement.

Software That Uses Artificial Intelligence To Screen Eyes For Diabetes Damage Approved By FDA

Morning Briefing

It’s the first screening device the FDA has authorized that doesn’t need a clinician’s interpretation to look for a particular condition. In other news, the agency also is going to relax its review of next-generation sequencing tests.

First Large-Scale Study Of Transgender Children Gets $1 Million Boost

Morning Briefing

Launched in 2013, the project has recruited more than 300 children ages 3-12 from 45 states, with the goal of tracking their development over 20 years. In other public health news: melanoma, brain damage, bathroom hand dryers, ovarian cancer, air pollution, “cool caps,” and more.

Interest In ‘Red Flag’ Gun Laws Surged Since Mass Shooting, But Many Say They Would Help More To Prevent Suicides

Morning Briefing

Nearly 60 percent of the 38,658 gun deaths in the U.S. in 2016 were people taking their own lives, and advocates say “red flag” laws, which allow officials to seize weapons from people who may be a threat to themselves or others, can play a role in combating that trend.

Cost To Collect Unpaid Health Premiums In Minnesota Would Cost More Than What Would Be Recovered

Morning Briefing

While Minnesota Department of Human Services wants to close its books on the matter, some Republicans in the GOP-controlled Legislature are pushing legislation that could force DHS to collect payments it’s owed by July 1.

The Good News And The Bad News: Drugs May Offer Relief To Migraine Sufferers, But They Come At High Cost

Morning Briefing

An analysis finds that the new medications, which could carry a $8,500 price tag, are not cost effective. In other pharmaceutical news, a gene therapy trial for Duchenne muscular dystrophy has begun, and an online pharmacy is fined for importing counterfeit cancer drugs.

Emotionally Fraught Debate Over Religious Objections To Abortions Heats Up

Morning Briefing

The Trump administration’s new division shields workers who object to abortion, assisted suicide, or other procedures they say violate their conscience or deeply held religious beliefs is sparking a legal, ethical and political battle over providing health care.

Drug Distributors Summoned To Testify In Front Of Congress About Their Role In Opioid Epidemic

Morning Briefing

The hearing, scheduled for May 8, is being likened to when tobacco executives were called in front of Congress in the 1990s. Representatives from McKesson, Cardinal Health, AmerisourceBergen, Miami-Luken and H.D. Smith Wholesale Drug Company will testify. Meanwhile, lawmakers continue to work toward a bipartisan package to get to the floor by May.

Puerto Rico’s Slow-Going Recovery Means New Hardship For Dialysis Patients

KFF Health News Original

Since massive Hurricane Maria struck in September and knocked out the dialysis center on the tiny satellite island of Vieques, more than a dozen patients needing treatment now must fly several times a week to the main island.

PrEP Campaign Aims To Block HIV Infection And Save Lives In D.C.

KFF Health News Original

Washington, D.C., is trying to stop new cases of HIV in the district by making sure residents who might be at risk are taking PrEP, medicine that cuts the risk of contracting the virus by 92 percent.

Podcast: KHN’s ‘What The Health?’ It’s Nerd Week

KFF Health News Original

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post discuss the Trump administration’s latest effort to revise rules for next year’s Affordable Care Act marketplaces. They also discuss state efforts to stabilize their individual markets in light of some of the changes being made at the federal level.